Transaction DateRecipientSharesTypePriceValue
24th September 2020Randal J Kirk21,428Grant/award etc.$3.50$74,998.00
16th September 2020Rick L. Sterling7,660Open or private sale$5.22$39,985.20
15th September 2020Rick L. Sterling25,000Exercise of derivative$0.00
12th August 2020Randal J Kirk16,824Open or private purchase$4.26$71,670.24
12th August 2020Randal J Kirk10,792Open or private purchase$4.26$45,973.92
12th August 2020Randal J Kirk30,514Open or private purchase$4.26$129,989.64
12th August 2020Randal J Kirk29,652Open or private purchase$4.26$126,317.52
12th August 2020Randal J Kirk10,779Open or private purchase$4.26$45,918.54
12th August 2020Randal J Kirk8,952Open or private purchase$4.26$38,135.52
12th August 2020Randal J Kirk10,775Open or private purchase$4.26$45,901.50
Aqua Bounty Technologies
Aqua Bounty Technologies logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


AquaBounty Technologies, Inc. is a biotechnology company. It focuses on the enhancement and improvement of the productivity in commercial aquaculture. The company was founded by Elliot Z. Entis and Garth L. Fletcher on December 17, 1991.


Ticker: AQB
Sector: Consumer Defensive
Industry: Farm Products
SEC Central Index Key (CIK): 1603978
Employees: 39
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $10 M (0%)
Inventory, Net: $2 M (0%)
Assets, Current: $13 M (196%)
Property, Plant and Equipment, Net: $25 M (0%)
Other Assets, Noncurrent: $44 Th (38%)
Assets: $38 M (27%)
Long-term Debt, Current Maturities: $140 Th (0%)
Accounts Payable, Current: $917 Th (13%)
Liabilities, Current: $2 M (16%)
Long-term Debt, Excluding Current Maturities: $4 M (0%)
Liabilities: $7 M (3%)
Common Stock, Value, Issued: $32 Th (48%)
Retained Earnings (Accumulated Deficit): $139 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $577 Th (60%)
Stockholders' Equity (Parent): $32 M (0%)
Liabilities and Equity: $38 M (27%)
Cost of Revenue: $1 M (-44%)
Research and Development: $636 Th (-47%)
Sales and Marketing: $137 Th (-26%)
General and Administrative Expenses: $2 M (-49%)
Operating Income/Loss: $4 M (-46%)
Other Income, net: $19 Th (-49%)